title: Magnitude, impact, and stability of primary headache subtypes: 30 year prospective Swiss cohort study.
abstract: OBJECTIVE
  To determine the prevalence, impact, and stability of different subtypes of headache in a 30 year prospective follow-up study of a general population sample.
  
  
  METHODS
  Prospective cohort study.
  
  
  METHODS
  Canton of Zurich, Switzerland.
  
  
  METHODS
  591 people aged 19-20 from a cohort of 4547 residents of Zurich, Switzerland, interviewed seven times across 30 years of follow-up.
  
  
  METHODS
  Prevalence of headache; stability of the predominant subtype of headache over time; and age of onset, severity, impact, family history, use of healthcare services, and drugs for headache subtypes.
  
  
  RESULTS
  The average one year prevalences of subtypes of headache were 0.9% (female:male ratio of 2.8) for migraine with aura, 10.9% (female:male ratio of 2.2) for migraine without aura, and 11.5% (female:male ratio of 1.2) for tension-type headache. Cumulative 30 year prevalences of headache subtypes were 3.0% for migraine with aura, 36.0% for migraine without aura, and 29.3% for tension-type headache. Despite the high prevalence of migraine without aura, most cases were transient and only about 20% continued to have migraine for more than half of the follow-up period. 69% of participants with migraine and 58% of those with tension-type headache manifested the same predominant subtype over time. However, the prospective stability of the predominant headache subtypes was quite low, with substantial crossover among the subtypes and no specific ordinal pattern of progression. A gradient of severity of clinical correlates and service use was present across headache subtypes; the greatest effect was for migraine with aura followed by migraine without aura, and then tension-type headache and unclassified headaches.
  
  
  CONCLUSIONS
  These findings highlight the importance of prospective follow-up of people with headache. The substantial longitudinal overlap among subtypes of headache shows the developmental heterogeneity of headache syndromes. Studies of the causes of headache that apply diagnostic nomenclature based on distinctions between discrete headache subtypes may not capture the true nature of headache in the general population.
authors.affiliation: National Institutes of Health, National Institute of Mental Health, Intramural Research Program, Genetic Epidemiology Research Branch, Bethesda, MD 20892-3720, USA. Kathleen.Merikangas@nih.gov
authors.forename: Kathleen R
authors.initials: KR
authors.lastname: Merikangas
authors.forename: Lihong
authors.initials: L
authors.lastname: Cui
authors.forename: Amanda Kalaydjian
authors.initials: AK
authors.lastname: Richardson
authors.forename: Hansruedi
authors.initials: H
authors.lastname: Isler
authors.forename: Suzan
authors.initials: S
authors.lastname: Khoromi
authors.forename: Erin
authors.initials: E
authors.lastname: Nakamura
authors.forename: Femke
authors.initials: F
authors.lastname: Lamers
authors.forename: Wulf
authors.initials: W
authors.lastname: Rössler
authors.forename: Vladeta
authors.initials: V
authors.lastname: Ajdacic-Gross
authors.forename: Alex
authors.initials: A
authors.lastname: Gamma
authors.forename: Jules
authors.initials: J
authors.lastname: Angst
mesh_terms: D000328:Adult; D017668:Age of Onset; D039721:Diagnostic and Statistical Manual of Mental Disorders; D018450:Disease Progression; D004812:Epidemiologic Methods; D005260:Female; D020022:Genetic Predisposition to Disease; D051270:Headache Disorders, Primary / Q000453:epidemiology* / Q000209:etiology / Q000473:pathology; D006801:Humans; D007406:Interview, Psychological; D008297:Male; D008875:Middle Aged; D004366:Nonprescription Drugs / Q000627:therapeutic use; D055553:Prescription Drugs / Q000627:therapeutic use; D011446:Prospective Studies; D013557:Switzerland / Q000453:epidemiology; D055815:Young Adult
chemical_list: D004366:Nonprescription Drugs; D055553:Prescription Drugs